Paxman (PAX.ST)
Paxman sells chemotherapy scalp-cooling systems, expanding US reimbursement and utilization after acquiring its largest competitor in 2025.
Substack
Everything we have picked from this writer, newest first.
Paxman sells chemotherapy scalp-cooling systems, expanding US reimbursement and utilization after acquiring its largest competitor in 2025.
Envista, Danaher’s dental spin-off, is pitched as a de-risked long-term opportunity after U.S.
AngelAlign holds 3% of global clear aligners and sells about HK$10,000 below Invisalign in Hong Kong, alongside speculation that MBK could…
ZimVie, a Zimmer Biomet dental and spine spinoff, fell below $150 million in market value after separation despite global sales reach and…
Essex Biotechnology trades at 8 times earnings despite patented Chinese biologics, near-60% niche market share and a portfolio built with…